ConductScience.org, home

Paper352264

Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli.

Suter W and 2 others. Antimicrob Agents Chemother, 1978. Cited by 84 papers, by iCite.

Cite this record

ConductScience Library. Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli. Papers, record 352264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/352264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
2.95
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Suter WW
2Rosselet AA
3Knüsel FF

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Escherichia coliMajor topic
QuinoxalinesMajor topic
Anaerobiosis
Chloramphenicol
DNA, Bacterial
Drug Resistance, Microbial
Macromolecular Substances
Mutation
Oxidation-Reduction

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14548053Letter: The yield of single-strand breaks in the DNA of bacteriophage lambda irradiated extra- and intracellularly with gamma-rays in oxic and anoxic conditions.Int J Radiat Biol Relat Stud Phys Chem Med1974https://conductscience.org/library/papers/4548053PubMed
24373040The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro.Biochemistry1974https://conductscience.org/library/papers/4373040PubMed
34553051Antibacterial properties of quindoxin: a new growth-promoting agent.Vet Rec1972https://conductscience.org/library/papers/4553051PubMed
44553750Inhibition of ribonucleic acid synthesis by myxin.Biochemistry1972https://conductscience.org/library/papers/4553750PubMed
54556973Induction of phage formation in lysogenic Escherichia coli by myxin.J Gen Microbiol1972https://conductscience.org/library/papers/4556973PubMed
64568763Pedigrees of some mutant strains of Escherichia coli K-12.Bacteriol Rev1972https://conductscience.org/library/papers/4568763PubMed
74599989An endonuclease from Escherichia coli that acts preferentially on UV-irradiated DNA and is absent from the uvrA and uvrB mutants.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4599989PubMed
84601366Some properties of mutants of Escherichia coli K12 defective in DNA polymerase I and exonuclease V.Mol Gen Genet1974https://conductscience.org/library/papers/4601366PubMed
94607624Isolation and characterization of an Escherichia coli K-12 mutant with a temperature-sensitive recA- phenotype.J Bacteriol1974https://conductscience.org/library/papers/4607624PubMed
104864404Mode of action of myxin on Escherichia coli.J Bacteriol1967https://conductscience.org/library/papers/4864404PubMed
114879097Studies on radiation-sensitive mutants of E. coli. I. Mutants defective in the repair synthesis.Mol Gen Genet1968https://conductscience.org/library/papers/4879097PubMed
124881840Lethal action and metabolic effects of streptonigrin on Escherichia coli.Mol Pharmacol1968https://conductscience.org/library/papers/4881840PubMed
134898990Characteristics of some multiply recombination-deficient strains of Escherichia coli.J Bacteriol1969https://conductscience.org/library/papers/4898990PubMed
144905190Effect of inhibitors of DNA synthesis of UV-sensitive derivatives of Escherichia coli strain K-12.Mutat Res1970https://conductscience.org/library/papers/4905190PubMed
154905567Quinoxaline-1, 4-di-N oxides. I. Inhibition of deoxyribonucleic acid synthesis in Escherichia coli by 2,3-dihydroxymethyl-quinoxaline-1, 4-di-N-oxide.Proc Soc Exp Biol Med1970https://conductscience.org/library/papers/4905567PubMed
164961479[Continuous recording of physico-chemical data in bacterial cultures. II. Influence of dissolved oxygen on the measurement of oxidation-reduction potentials in bacterial cultures].Z Allg Mikrobiol1965https://conductscience.org/library/papers/4961479PubMed
174119484Action of bleomycin on DNA and RNA.Eur J Biochem1972https://conductscience.org/library/papers/4119484PubMed
185072575The growth promoting activity of quinoxaline-I, 4-dioxide (quindoxin) in young chicken (Gallus domesticus).Res Vet Sci1972https://conductscience.org/library/papers/5072575PubMed
195327367Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality.J Bacteriol1966https://conductscience.org/library/papers/5327367PubMed
205327370Mechanism of action of nalidixic acid on Escherichia coli. IV. Effects on the stability of cellular constituents.J Bacteriol1966https://conductscience.org/library/papers/5327370PubMed

See all 38 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
42221845Synergistic Effects of Thymoquinone, 3-Hydrazinoquinoxaline-2-Thiol, and Amphotericin B Against Methicillin-Resistant Staphylococcus aureus: In vitro and in silico Evaluation.Int J Gen Med2026https://conductscience.org/library/papers/42221845PubMed
40791182Thymoquinone and 3HQ synergy inhibits CTX-M-15 ESBL.Biomol Biomed2025https://conductscience.org/library/papers/40791182PubMed
40332345A Quinoxaline 1,4-Dioxide Activates DNA Repair Systems in Mycobacterium smegmatis: A Transcriptomic Study.Int J Mol Sci2025https://conductscience.org/library/papers/40332345PubMed
40172295Unveiling the synergistic power of 3-hydrazinoquinoxaline-2-thiol and vancomycin against MRSA: An in vitro and in silico evaluation.Biomol Biomed2025https://conductscience.org/library/papers/40172295PubMed
38283148Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity.Front Genet2023https://conductscience.org/library/papers/38283148PubMed
37631089Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37631089PubMed
36620005Dietary supplementation of Bacillus subtilis or antibiotics modified intestinal microbiome of weaned pigs under enterotoxigenic Escherichia coli infection.Front Microbiol2022https://conductscience.org/library/papers/36620005PubMed
35215268Synthesis and Characterization of Novel 2-Acyl-3-trifluoromethylquinoxaline 1,4-Dioxides as Potential Antimicrobial Agents.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35215268PubMed
33573321Metabolomic Profile of Weaned Pigs Challenged with E. coli and Supplemented with Carbadox or Bacillus subtilis.Metabolites2021https://conductscience.org/library/papers/33573321PubMed
33546407The Spectrum of Antimicrobial Activity of Cyadox against Pathogens Collected from Pigs, Chicken, and Fish in China.Antibiotics (Basel)2021https://conductscience.org/library/papers/33546407PubMed
33182563Development of Resistance in Escherichia coli ATCC25922 under Exposure of Sub-Inhibitory Concentration of Olaquindox.Antibiotics (Basel)2020https://conductscience.org/library/papers/33182563PubMed
32877510Bacillus subtilis: a potential growth promoter in weaned pigs in comparison to carbadox.J Anim Sci2020https://conductscience.org/library/papers/32877510PubMed
28968083Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.J Med Chem2017https://conductscience.org/library/papers/28968083PubMed
28858261Voltammetric Study of Some 3-Aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide Derivatives with Anti-Tumor Activities.Molecules2017https://conductscience.org/library/papers/28858261PubMed
28785420A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli.Microb Genom2017https://conductscience.org/library/papers/28785420PubMed
28018297Mechanisms of Antibacterial Action of Quinoxaline 1,4-di-N-oxides against Clostridium perfringens and Brachyspira hyodysenteriae.Front Microbiol2016https://conductscience.org/library/papers/28018297PubMed
27047380Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.Front Pharmacol2016https://conductscience.org/library/papers/27047380PubMed
26296207Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli.PLoS One2015https://conductscience.org/library/papers/26296207PubMed
26087764Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.Curr Med Chem2015https://conductscience.org/library/papers/26087764PubMed
18625764Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18625764PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/352264

GET https://conductscience.org/api/papers/v1/352264/references?page=2